Soligenix (SNGX) Gross Margin Growth (5y) (2015 - 2023)
Soligenix (SNGX) Gross Margin Growth (5y) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Soligenix | 6.45 Mn | 6.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -300.00 |
| Sep 30, 2023 | 490.00 |
| Jun 30, 2023 | -237.00 |
| Mar 31, 2023 | -47.00 |
| Dec 31, 2022 | 4,185.00 |
| Sep 30, 2022 | 300.00 |
| Jun 30, 2022 | -1,621.00 |
| Mar 31, 2022 | 3,267.00 |
| Dec 31, 2021 | -1,316.00 |
| Sep 30, 2021 | -42.00 |
| Jun 30, 2021 | -2,098.00 |
| Mar 31, 2021 | 194.00 |
| Sep 30, 2020 | 1,513.00 |
| Jun 30, 2020 | -157,275.00 |
| Mar 31, 2020 | -26,782.00 |
| Dec 31, 2019 | -678.00 |
| Sep 30, 2019 | 624.00 |
| Jun 30, 2019 | 1,613.00 |
| Mar 31, 2019 | -1,198.00 |
| Dec 31, 2018 | -1,304.00 |